0.30Open0.30Pre Close0 Volume1 Open Interest0.50Strike Price0.00Turnover0.00%IV-3.09%PremiumMay 16, 2025Expiry Date0.31Intrinsic Value100Multiplier15DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.65Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Beyond Air Stock Discussion
Beyond Air Receives U.S. Patent Covering Treatment of NTM Infections Using Gaseous Nitric Oxide
Beyond Air Granted U.S. Patent Covering Treatment of Ntm Infections Using Gaseous Nitric Oxide (Gno)
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
Thursday, 24th April at 4:05 pm
GARDEN CITY, N.Y., April 24, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that the United States Patent and Trademark Office (USP...
any potential of uptrend ?
seems hopeless
No comment yet